SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for NANOVIRICIDES, INC. (NNVC) (CIK 0001379006) (NNVC) — Jul 10, 2012

NANOVIRICIDES, INC. (NNVC) (CIK 0001379006)
Date: July 10, 2012 · CIK: 0001379006 · Accession: 0000000000-12-035908

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 000-52318

Date
July 10, 2012
Author
/s/ Joel Parker
Form
UPLOAD
Company
NANOVIRICIDES, INC. (NNVC) (CIK 0001379006)

Letter

July 10 , 201 2 Via E -mail Eugene Seymour, M.D. Chief Executive Officer and Interim Chief Financial Officer and Director Nanoviricides , Inc. 135 Wood Street, Suite 205 West Haven, CT 06516

Re: Nanoviricides , Inc . Form 10-K for the Fiscal Year Ended June 30 , 201 1 Filed October 13 , 2011 File No. 000-52318

Dear Dr. Seymour :

We have completed our review of your filing. We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not asse rt staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,
/s/ Joel Parker

Show Raw Text
July 10 , 201 2

Via E -mail
Eugene Seymour, M.D.
Chief Executive Officer and
Interim Chief Financial Officer  and Director
Nanoviricides , Inc.
135 Wood Street, Suite 205
West Haven, CT 06516

Re: Nanoviricides , Inc .
Form 10-K for the Fiscal Year Ended June 30 , 201 1
 Filed October 13 , 2011
File No. 000-52318

Dear Dr. Seymour :

We have completed our review of your filing.  We remind you that our comments or
changes to disclosure in response to our comments do not foreclose the Commission from taking
any action with respect to the company or the filing and the company may not asse rt staff
comments as a defense in any proceeding initiated by the Commission or any person under the
federal securities laws of the United States.  We urge all persons who are responsible for the
accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the
information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,

 /s/ Joel Parker

Joel Parker
Accounting Branch Chief